The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer-Reference-Cited by-同舟云学术

The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer

Published:2017-06-13 Issue:11 Volume:44 Page:1832-1844
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Murray Iain^ORCID,Chittenden Sarah J.,Denis-Bacelar Ana M.,Hindorf Cecilia,Parker Christopher C.,Chua Sue,Flux Glenn D.

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00259-017-3744-y/fulltext.html

Reference35 articles.

1. Gartrell BA, Saad F. Managing bone metastases and reducing skeletal related events in prostate cancer. Nat rev Clin Oncol. 2014;11:335–45. doi: 10.1038/nrclinonc.2014.70 .

2. Bodei L, Lam M, Chiesa C, Flux G, Brans B, Chiti A, et al. EANM procedure guideline for treatment of refractory metastatic bone pain. Eur J Nucl med Mol Imaging. 2008;35:1934–40. doi: 10.1007/s00259-008-0841-y .

3. Florimonte L, Dellavedova L, Maffioli LS. Radium-223 dichloride in clinical practice: a review. Eur J Nucl med Mol Imaging. 2016;43:1896–909. doi: 10.1007/s00259-016-3386-5 .

4. Hobbs RF, Song H, Watchman CJ, Bolch WE, Aksnes AK, Ramdahl T, et al. A bone marrow toxicity model for Ra-223 alpha-emitter radiopharmaceutical therapy. Phys med Biol. 2012;57:3207–22. doi: 10.1088/0031-9155/57/10/3207 .

5. Nilsson S, Larsen RH, Fossa SD, Balteskard L, Borch KW, Westlin JE, et al. First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases. Clin Cancer res. 2005;11:4451–9. doi: 10.1158/1078-0432.ccr-04-2244 .

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone Metastases;The Cancer Journal;2024-05

2. ISIT-QA: In Silico Imaging Trial to Evaluate a Low-Count Quantitative SPECT Method Across Multiple Scanner–Collimator Configurations for²²³Ra-Based Radiopharmaceutical Therapies;Journal of Nuclear Medicine;2024-04-04

3. WIN-PDQ: a Wiener-estimator-based projection-domain quantitative SPECT method that accounts for intra-regional uptake heterogeneity;Medical Imaging 2024: Physics of Medical Imaging;2024-04-01

4. Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response;JNCI Cancer Spectrum;2023-10-03

5. The value of baseline 18F-sodium fluoride and 18F-choline PET activity for identifying responders to radium-223 treatment in castration-resistant prostate cancer bone metastases;European Radiology;2023-08-24